474 related articles for article (PubMed ID: 21289053)
21. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II.
Ohtsu H; Dempsey PJ; Frank GD; Brailoiu E; Higuchi S; Suzuki H; Nakashima H; Eguchi K; Eguchi S
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):e133-7. PubMed ID: 16840716
[TBL] [Abstract][Full Text] [Related]
22. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.
Maretzky T; Evers A; Zhou W; Swendeman SL; Wong PM; Rafii S; Reiss K; Blobel CP
Nat Commun; 2011; 2():229. PubMed ID: 21407195
[TBL] [Abstract][Full Text] [Related]
23. Insulin-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor in adipocytes in vitro.
Yamamoto T; Suganami T; Kiso-Narita M; Scherle PA; Kamei Y; Isobe M; Higashiyama S; Ogawa Y
Obesity (Silver Spring); 2010 Oct; 18(10):1888-94. PubMed ID: 20111015
[TBL] [Abstract][Full Text] [Related]
24. A disintegrin and metalloproteinase 17 (ADAM17) mediates epidermal growth factor receptor transactivation by angiotensin II on hepatic stellate cells.
Oikawa H; Maesawa C; Tatemichi Y; Nishinari Y; Nishiya M; Mizugai H; Ikeda A; Oikawa K; Takikawa Y; Masuda T
Life Sci; 2014 Mar; 97(2):137-44. PubMed ID: 24412389
[TBL] [Abstract][Full Text] [Related]
25. Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes.
Flannery PJ; Spurney RF
Nephron Exp Nephrol; 2006; 103(3):e109-18. PubMed ID: 16554661
[TBL] [Abstract][Full Text] [Related]
26. Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism.
Murillo MM; Carmona-Cuenca I; Del Castillo G; Ortiz C; Roncero C; Sánchez A; Fernández M; Fabregat I
Biochem J; 2007 Jul; 405(2):251-9. PubMed ID: 17407446
[TBL] [Abstract][Full Text] [Related]
27. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
[TBL] [Abstract][Full Text] [Related]
28. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
[TBL] [Abstract][Full Text] [Related]
29. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1.
Moreno-Càceres J; Mainez J; Mayoral R; Martín-Sanz P; Egea G; Fabregat I
FEBS J; 2016 Apr; 283(7):1300-10. PubMed ID: 26815118
[TBL] [Abstract][Full Text] [Related]
30. Akt and RhoA activation in response to high glucose require caveolin-1 phosphorylation in mesangial cells.
Wu SZ; Peng FF; Li JL; Ye F; Lei SQ; Zhang BF
Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1308-17. PubMed ID: 24694591
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.
Huang S; Zhang A; Ding G; Chen R
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1323-33. PubMed ID: 19339632
[TBL] [Abstract][Full Text] [Related]
32. High glucose-induced RhoA activation requires caveolae and PKCβ1-mediated ROS generation.
Zhang Y; Peng F; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F159-72. PubMed ID: 21975875
[TBL] [Abstract][Full Text] [Related]
33. A disintegrin and metalloenzyme (ADAM) 17 activation is regulated by α5β1 integrin in kidney mesangial cells.
Gooz P; Dang Y; Higashiyama S; Twal WO; Haycraft CJ; Gooz M
PLoS One; 2012; 7(3):e33350. PubMed ID: 22413019
[TBL] [Abstract][Full Text] [Related]
34. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries.
Lucchesi PA; Sabri A; Belmadani S; Matrougui K
Circulation; 2004 Dec; 110(23):3587-93. PubMed ID: 15557365
[TBL] [Abstract][Full Text] [Related]
35. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
[TBL] [Abstract][Full Text] [Related]
36. Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway.
Panigone S; Hsieh M; Fu M; Persani L; Conti M
Mol Endocrinol; 2008 Apr; 22(4):924-36. PubMed ID: 18187604
[TBL] [Abstract][Full Text] [Related]
37. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF.
Krieg T; Cui L; Qin Q; Cohen MV; Downey JM
J Mol Cell Cardiol; 2004 Mar; 36(3):435-43. PubMed ID: 15010282
[TBL] [Abstract][Full Text] [Related]
39. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
40. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
